Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China National Seed Group is a large state-owned Chinese seed company focused on crop breeding, seed production, processing, marketing, and agricultural technology services. Originally established in 1978 from the Seed Bureau of the Ministry of Agriculture, it has become a core seeds business within Syngenta Group China and a subsidiary within the Sinochem/China Syngenta agricultural system. The company operates across major crop categories including corn, rice, wheat, oil-bearing crops, and vegetables, with strong emphasis on integrated breeding, propagation, and commercialization. Its business is centered on modern crop seed innovation and large-scale agricultural deployment rather than human therapeutics or healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China National Seed Group.